TakeBOM:532890 -3.71%31 Forward Dividend Yield % is 0.00% as of Jul. 10, 2026. GuruFocus rates BOM:532890 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Take ranks worse than 362318.48% on this metric.
As of today (2026-07-10), the Forward Annual Dividend Yield of Take is 0.00%.
As of today (2026-07-10), the Trailing Annual Dividend Yield of Take is 0.00%.
BOM:532890's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.535 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Take was 100.00% per year. The lowest was -26.30% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Take (BOM:532890) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
BOM:532890 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Health Information Services subindustry, Take's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Take Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Take's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Take's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Take (BOM:532890) has a Forward Dividend Yield % of 0.00% as of Jul. 10, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Take and its competitors. According to the industry distribution chart, Take ranks #999999 out of 276 companies in the Healthcare Providers & Services industry.
Is Take's Forward Dividend Yield % too high?
Take's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Take ranks #999999 out of 276 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Take has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Take's Forward Dividend Yield % compare to VRTX and REGN?
According to the Healthcare Providers & Services industry distribution chart, Take ranks #999999 out of 276 companies for Forward Dividend Yield %. This places Take in the lower half of its industry. The industry median Forward Dividend Yield % is 2.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.54, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Take and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Take's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Take stock overvalued right now?
Take (BOM:532890) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Take's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Take (BOM:532890), the current Forward Dividend Yield % is 0.00% as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Take Solutions Ltd is a technology solutions provider specializing in Life Sciences and Supply Chain Management services. The company offers integrated services including clinical research, generics support, regulatory affairs, pharmacovigilance, and data sciences. It supports pharmaceutical, biotech, and medical device companies to various countries with technology-backed solutions that enhance drug development and regulatory compliance. Revenue is driven by its broad portfolio of IT-enabled services focused on the life sciences industry and supply chain management, catering to a client base of innovators, generics manufacturers, and biotech firms.
31GF Score
Get the complete analysis for BOM:532890
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532890 has been successfully added to your 